Around Town

Watertown Company Creating Way to Dramatically Cut the Number of Pills Patients Take

By |

Lyndra TherapeuticsA prototype of Lyndra’s stellate medical platform is placed in a machine to undergo stress testing. A company with headquarters in the East End of Watertown will soon start the final trials for a way of delivering drugs that would allow patients to take just one pill a week instead of seven pills or more. And the company is working on technology that could cut it to just two or even one a pill a month. Lyndra Therapeutics moved to its space on Grove Street in 2017, and employs nearly 130 people there, in Lexington, or who work remotely. The company also helps train the next generation of life scientists by working with students from colleges in the area, and has also started reaching out to classes at Watertown High School.

Business

Watertown Company Acquired by Major Pharmaceutical Firm

By |

The following announcement came from Novo Nordisk:

Novo Nordisk and Forma Therapeutics, Holdings Inc. (Nasdaq: FMTX) today announced that they have entered into a definitive agreement under which Novo Nordisk will acquire Forma Therapeutics for USD 20 per share in cash, which represents a total equity value of USD 1.1bn. Forma Therapeutics is a clinical-stage biopharmaceutical company focused on transforming the lives of patients with sickle cell disease (SCD) and rare blood disorders. The acquisition of Forma Therapeutics, including its lead development candidate, etavopivat, is aligned with Novo Nordisk’s strategy to complement and accelerate its scientific presence and pipeline in haemoglobinopathies, a group of disorders in which there is abnormal production or structure of the haemoglobin protein in the red blood cells. “Novo Nordisk has worked for more than 40 years to develop and deliver transformative medicines to patients around the world with rare and devastating diseases. By adding Forma’s differentiated approach to address unmet needs for patients, we are taking a step forward in enhancing our sickle cell disease pipeline,” said Ludovic Helfgott, executive vice president and head of Rare Disease at Novo Nordisk.

Biotech

Watertown Company Developing COVID Therapy, Trying to Inspire Future Scientists

By |

Charlie BreitroseBryan Goodwin, chief biologist at Enanta Pharmaceuticals, and Watertown High School Senior Phil Centola look at a new microscope donated by the biotech company. Watertown-based Enanta Pharmaceuticals has a potential therapy for COVID-19 ready for human testing, and it also hopes to develop some future scientists with a donation to Watertown High School. On Monday morning, representatives from Enanta presented three new microscopes donated by the company to the WHS Science Department. The equipment can be hooked up to a tablet or cellphone to make it easier to see objects under magnification, and images can even be shared with other devices. The school had one of the microscopes, said Lynsey Kraemer, the district’s Science Curriculum Coordinator for Grades 8-12, but the district could not afford more.

100 Forge

9 Story Building at Arsenal Yards Fully Leased, 5 Life Science Tenants Coming 100 Forge

By |

Boylston PropertiesA rendering of what the nine-story 100 Forge building at Arsenal Yards will look like. Developers are creating 165,000 sq. ft. of space for biotech companies. The following announcement was provided by Boylston Properties:

Boylston Properties, a Boston-based developer of mixed-use destinations, today announced that 100 Forge, its 165,595 s.f. life sciences building in the heart of Arsenal Yards in Watertown, is fully leased.

Around Town

Hear About Biotech’s Impact from Co-founder of Moderna at Charles River Chamber’s Fall Breakfast

By |

The Charles River Regional Chamber will host its annual Fall Breakfast on Wednesday Nov. 17, 2021 from 10-11:30 a.m.

The Chamber sent out the following information:

Our Fall Business Breakfast returns – virtually – on Wed. Nov. 17th. This signature annual event – our 106th – is a celebration of the leadership, resilience and impact of our region’s businesses and nonprofits.

23 Elm St.

Life Science Building in East Watertown Approved by Zoning Board

By |

Elm Street PartnersA rendering of the new life science lab building approved to be built at 23 Elm St. The building to the right is the Residence Inn by Marriott hotel. Months after it first appeared before the Zoning Board of Appeal, a three story life science lab building at 23 Elm Street got approval to be constructed on Wednesday night. The proposal first came before the ZBA in February, at a meeting where board members expressed their concerns about the amount of parking for the then 78,000 sq. ft.

Business

Get to Know Watertown Life Sciences in a Virtual Panel of Biotech Execs – Submit Your Questions

By |

Leaders of Watertown’s newest industry will be talking about their companies and the influx of life science into Town during the Watertown Business Coalition’s virtual event. A recent survey found about 50 biotech firms located in Watertown of various sizes and stages of development. Get to know life sciences from a panel of five executives from four life science companies located in Watertown. The event will be held on Thursday, April 29 from 4-5 p.m. To RSVP click here. The WBC’s Life Science Panel will include: Joanne Kamens, Executive Director of Addgene; Mark Bamforth, Founder, Exec.

Biotech

Former Watertown Flag Company Turned into Life Science Space

By |

A former flag factory in Watertown has been transformed into life science lab space. The former New England Flag and Banner building at 165 Dexter Ave. has been renovated and prepared for life science labs. The following information was provided by Ebbrell Architecture + Design:

Enticed by an open floor plan flooded with natural light, executives at startup Via Separations knew they found the perfect home in a former Watertown flag factory. Massachusetts-based Ebbrell Architecture + Design, a certified Woman-owned Business Enterprise, worked closely with Via Separations in rolling out a phased plan for the new headquarters, complete with a state-of-the-art wet lab that houses eight fume hoods — six benchtops and two walk-ins — as well as extensive prototyping space for the company’s revolutionary membrane filtration research.